Lutronic, a leading innovator of aesthetic and medical laser and energy-based technology, furthers its commitment to education in the aesthetic medical community through the support of events in the United States and China this month.
Lutronic attended and featured educational events at American Society for Dermatologic Surgery (ASDS) in Chicago on October 15-18, 2015. We are especially pleased to announce the success of the workshop entitled “ASDS Symposium: Deliver the power of RF with the precision of a laser”. The workshop featured presentations by Dr. Joely Kaufman, Skin associates of South Florida, and Dr. Joel Cohen, About Skin Dermatology in Denver Colorado, both global experts in aesthetics devices. They presented on their extensive positive experiences and patient successes utilizing Infini, a High Intensity Focused RF device, particularly in the treatment of acne scars and wrinkles and texture of the aging neck. Dr. Cohen also presented some of the findings that were highlighted as part of a Case Report published in the September issue of Journal of Drugs in Dermatology entitled ‘Treatment of Acne Scars With High Intensity Focused Radio Frequency’.
Lutronic also continues to strengthen its presence in the China market by showcasing its cutting edge devices at the 11th Annual Meeting of Chinese Dermatologist Association & National Congress of Cosmetic Dermatology in Chengdu on November 12-15, 2015. It featured 5 devices including, ACTION II, a non-surgical, non-invasive treatment for vaginal rejuvenation, eCO2, a Dual Mode CO2 Laser, Healite, a LED Phototherapy system, SPECTRA, a Nd:YAG-based Multi-platform and SOLARI, a Square Pulse IPL device. This ongoing commitment around the globe to educational events and regional events will help to ensure that Lutronic will grow its footprint in the global aesthetic market.
The American Society for Dermatologic Surgery (ASDS) is the largest specialty organization in the United States exclusively representing dermatologic surgeons who have unique training and experience to treat the health, function and beauty of skin throughout every stage of life. ASDS members are recognized as leaders in the field of cosmetic and medically necessary skin surgery. They also are pioneers in the field; many are involved in the clinical studies that bring popular treatments to revitalize skin and fill and diminish wrinkles to the forefront. Their work has helped create and enhance many of the devices that tighten skin and remove blemishes, hair and fat. Dermatologic surgeons also are experts in skin cancer prevention, detection and treatment. As the incidence of skin cancer rises, dermatologic surgeons are committed to taking steps to minimize the life-threatening effects of this disease. ASDS supports its more than 5,800 members through educational opportunities, networking forums, mentoring programs, public awareness activities, leadership activities and advocacy efforts (through the American Society for Dermatologic Surgery Association).
China Dermatologist Association, CDA is the largest Dermatologist society in China and has been operating for 11 years now. Clinical and aesthetic dermatologists, scientists and other industry professionals gathered together for learning, training and exchange of ideas on current dermatology issues.
Lutronic, a leading innovator in advanced aesthetic and medical laser and related technology, was established over 18 years ago to bring intuitive, robust, versatile devices that are affordable and efficacious to the worldwide medical community. Committed to improving medicine, Lutronic partners with key opinion leaders to advance science and ensure the efficacy of its systems. All systems are versatile and offer multiple setting and treatment options for customized treatments, which optimize outcomes for a wide variety of conditions and treatments including melasma, tattoo removal, soft tissue incision, vascular lesions, hair removal, wrinkle reduction, rejuvenation, body/face contouring, chronic pain, healing and more.
With a focus on physician needs and patient outcomes, Lutronic dedicates time and funding toward the development of devices that offer features and improvements not found in today’s market. Devoting more than 20% of revenues to R&D, Lutronic holds more than 200 current and pending patents worldwide. With more than 260 employees worldwide, Lutronic has offices in the US, Korea, China, and Japan, a worldwide network of distributors, focused R&D centers in both the US and Korea, and is ever expanding.
For more information about Lutronic visit: http://www.lutronic.com